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Abstract
Cardiovascular disease, which consists of hypertension, coronary heart disease, 
and cerebrovascular accidents, affects over 82 million American adults and is currently 
the leading cause o f death in the United States. The Center for Disease Control and 
Prevention (CDC) identifies high-blood cholesterol as one of the main risk factors in the 
development of these diseases. Furthermore, 71 million Americans report having a 
high-blood cholesterol level, yet only about one third of those people have it under 
control (CDC, 2014c).
The National Cholesterol Education Program Adult Treatment Panel III (NCEP 
ATP III) guidelines recommend that adults 20 years or older be screened for high 
cholesterol once every 5 years. The purpose of the current research was to determine if 
primary care providers are screening adults between the ages of 20 and 40 years for 
high-blood cholesterol levels, according to recommendations stated in NCEP ATP III 
guidelines. The current research also identified the presence of cardiovascular disease 
risk factors in patients who were screened for cholesterol levels and who were not 
screened for cholesterol levels.
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The questions asked by the current research included: Are primary care 
providers performing a fasting lipoprotein profile on patients between the ages o f 20 
and 40 years once every 5 years? Were risk factors present in the patients who had a 
fasting lipoprotein profile performed? Were risk factors present in the patients who did 
not have a fasting lipoprotein profile performed?
The current research utilized a quantitative, retrospective chart review o f 500 
patient charts from 5 participating clinics. All charts belonging to patients between the 
ages of 20 and 40 years were eligible. These charts were reviewed for adherence to the 
NCEP ATP III guidelines and were further reviewed for certain cardiovascular risk 
factors identified within the NCEP ATP III guidelines indicating the need for cholesterol 
screening.
Once data were compiled, it was analyzed by descriptive statistics. Based on the 
research data, primary care providers are not consistently following the NCEP ATP III 
guidelines for routinely performing cholesterol screening in adults between the ages of 
20 and 40 years. The current research concluded that primary care providers need 
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CHAPTER I 
Dimensions of the Problem
Cardiovascular disease, which consists o f hypertension, coronary heart disease, 
and cerebrovascular accidents, affects over 82 million American adults and is currently 
the leading cause of death in the United States (Centers for Disease Control and 
Prevention, 2014b). The Centers for Disease Control and Prevention (CDC) (2014a) 
identifies high-blood cholesterol as one o f the main risk factors in the development o f 
these diseases. Furthermore, 71 million Americans report having a high-blood 
cholesterol level, yet only about one third of those people have their blood cholesterol 
level under control (CDC, 2014c).
A large number of individuals living in the southeastern portion of the United 
States report having high-blood cholesterol levels— a factor contributing to the highest 
prevalence of cardiovascular disease mortality in the nation (CDC, 2015). A simple and 
effective way to prevent these diseases is to screen for high-blood cholesterol levels and 
introduce appropriate lifestyle modifications and treatment (CDC, 2014c). While the 
CDC (2012) reports screening rates have improved among primary care providers, only 
a handful of states meet the Healthy People 2020 objective of an 82% screening rate.
Understanding cholesterol and its role in the development of cardiovascular 
disease is essential before one can understand why cholesterol screening and 
management are imperative. Cholesterol is a fatty substance found in many foods and 
is necessary for proper body function and metabolism. However, cholesterol, in 
particular low-density lipoprotein (LDL), can build up in the arteries. Too much 
cholesterol or an abnormal amount of certain cholestérols, known as dyslipidemia, can 
cause decreased ability o f the vessels in the vascular system to dilate and can cause
hardening of the arterial walls, commonly known as arteriosclerosis. Cholesterol 
buildup and a loss of vasodilation result in a narrowed vessel, reducing the amount o f 
blood that can pass through at any given time. Compromised vasculature causes a rise 
in peripheral vascular resistance and, in turn, causes a rise in a person’s blood pressure. 
High blood pressure, a systolic reading >140 and a diastolic reading > 90, causes 
further damage and hardening to the vessel walls. Cholesterol plaque buildup can 
eventually dislodge from the vessel walls, resulting in potentially devastating events, 
including a myocardial infarction (MI), also known as a heart attack, or cerebrovascular 
accident, also known as a stroke (National Health, Lung, and Blood Institute [NHLBI], 
2012).
The National Cholesterol Education Program Adult Treatment Panel III (NCEP 
ATP III) guidelines recommend that adults 20 years or older be screened for high 
cholesterol once every 5 years (2002). A fasting lipoprotein panel is a simple blood test 
that can be performed in a primary care provider’s office. The panel provides 
quantitative cholesterol levels, including total cholesterol, low-density lipoprotein, high- 
density lipoprotein, and triglycerides (James & Cleeman, 2001). The guidelines focus 
on monitoring and lowering abnormally high LDL levels because high LDL levels have 
been linked to an increased risk of developing cardiovascular disease (NCEP, 2002). 
Target LDL levels were defined by the NCEP ATP III guidelines as an LDL <100 
mg/dL (NCEP ATP III, 2002). A fasting lipoprotein profile requires that the patient 
abstain from food and drink for 8 to 12 hours before blood work is obtained (James & 
Cleeman, 2001).
High LDL levels can be easily detected and managed with increased adherence 
to NCEP ATP III guidelines by primary care providers. However, compliance of
screening by providers for high-blood cholesterol, namely among the young adult 
population, continues to be at a seemingly low rate (CDC, 2012). Failure to identify 
high LDL levels in adults between the ages of 20 and 40 years, especially those who 
have cardiovascular disease risk factors, increases his or her risk of developing 
cardiovascular disease earlier in life (James & Cleeman, 2001). Identifying cholesterol 
levels early allows the provider to identify at-risk patients and introduce interventions, 
such as preventative education, lifestyle modification, and medication therapy, to slow 
the development or progression o f cardiovascular disease and reduce morbidity rates 
(James & Cleeman, 2001).
Purpose of Research
The purpose of the current research was to determine if  primary care providers 
are screening adults between the ages o f 20 and 40 years for high-blood cholesterol 
levels according to recommendations stated in the NCEP ATP III guidelines. The study 
also identified the presence of cardiovascular disease risk factors in patients who were 
screened for cholesterol levels and who were not screened.
Significance of Study
Nursing. Nurses and advanced practice nurses play an integral role in health 
promotion and disease prevention. Nurses, along with primary care providers, improve 
the health o f patients using evidence-based recommendations, while also promoting 
healthy behaviors such as screenings to prevent disease processes from occurring. It is 
important for nurses, as well as advanced practice nurses in a primary care provider 
role, to be aware o f populations at risk for developing cardiovascular diseases.
Advanced practice nurses must obtain a pertinent health history on each patient 
to include past medical history, family history, and social history. A thorough history
and physical performed by the advanced practice nurse or primary care provider is a key 
component when deciding which patients require particular screenings. In this case, the 
advanced practice nurse should be familiar with current guidelines and 
recommendations and promote cholesterol screening on all patients age 20 years or 
older.
The current research will aid advanced practice nurses in becoming familiar 
with current guidelines on cholesterol screening in young adults. The current research 
also brought to light the cholesterol screening practices, or lack thereof, o f primary care 
providers. Increasing awareness and familiarity with current guidelines will allow 
advanced practice nurses to better promote healthy behaviors, properly screen patients 
for high cholesterol, and prevent or manage related diseases accordingly.
Education. Education is a key component in primary care practice. Healthcare 
professionals use education as a tool to convey pertinent information to patients in 
regard to their health and health maintenance. Studies suggest that thorough patient 
education by the primary care provider improves patients’ self-efficacy when managing 
their own health (Bodenheimer, Lorig, Holman, & Grumbach, 2002). Patients and 
primary care providers alike are required to make educated decisions regarding healthy 
behaviors, such as screenings for disease prevention.
The current research will assist in the education of primary care providers, 
healthcare professionals, and the general public on the significance o f cholesterol, 
cholesterol’s effect on the development o f cardiovascular disease, and the importance of 
cholesterol screenings to detect and treat high cholesterol levels. The current research 
will also educate primary care providers on the disparities of cholesterol screenings in
young adults, as well as raise awareness of populations at risk for developing 
cardiovascular disease.
Research. Research performed by, or in conjunction with, healthcare 
professionals’ aids in education and quality improvement of primary care providers. A 
study by Nagykaldi and Mold (2006) showed how practice facilitators and practice- 
based research networks collaborate with primary care providers in performing research 
to improve quality o f care delivered. Chart auditing is a method used by practice 
facilitators to gather and utilize data to aid primary care providers in targeting areas in 
need of improvement (Nagykaldi & Mold, 2006). Data collected in the current research 
will provide primary care providers and other healthcare professionals with data needed 
to improve cholesterol screening practices in the primary care setting.
Conceptual Framework
Nola Pender’s Health Promotion Model (HPM) was used as the theoretical 
foundation for the current research. Pender’s model o f health promotion is one of the 
contemporary nursing models that predict health behavior (Vakili, Rahaei, Nadrian, & 
YarMohammadi, 2011). In the current research, the HPM was used as a guide to 
determine how healthcare providers emphasized the importance of cholesterol 
screening.
Nola Pender introduced the current HPM in 1996. The HPM is a nursing theory 
developed to understand and predict what factors, including biological, psychological 
and environmental, determine a person’s health behaviors. Pender believed that for a 
person to be successful in health promotion a behavior must be perceived as beneficial 
and the person must believe they have the ability to achieve the behavior. For example, 
a person should not only be without a diseased heart, a person should actively engage in
behaviors to promote cardiovascular health because the person views a healthy heart as 
important. In contrast to other models, the HPM emphasizes health promotion and 
disease prevention using positive motivation. The model is used to predict health- 
promoting and health-protecting behaviors. The desired outcome o f the HPM is a 
health-promoting behavior (George, 2011).
An assumption of the HPM states that patients will seek to actively regulate 
their own behavior (Pender, 1996). If a patient has made the effort to make an 
appointment with a primary care provider, the patient has taken the first step in 
regulating his or her health. Pender also assumed that a primary care provider is a part 
o f the interpersonal environment and has the potential to make an impact on the 
individual’s health throughout his or her lifetime (Pender, 1996). In the current 
research, the primary care provider had an opportunity to make an impact on the 
patient’s life and health by performing a fasting lipoprotein panel. A primary care 
provider also had a chance to impact patients by informing them of the risk factors that 
may increase their cholesterol and by introducing interventions to improve their 
cardiovascular health. When a patient views cholesterol screening as important, he or 
she may be more likely to participate in a preventative treatment plan.
Self-efficacy was noted as an important factor o f the HPM (Pender, 1996). 
Pender (1996) defined self-efficacy as the judgment o f personal capability to organize 
and execute a particular health behavior and self-confidence in performing the health 
behavior successfully. The current research looks closely at a primary care provider’s 
self-efficacy related to cholesterol screening practices. If the provider views cholesterol 
screening and management as important, there is a greater chance the patient will view 
screening and management as important to his or her overall health. Introducing and
educating young adults on the importance of cholesterol screenings can delay or even 
prevent the onset o f cardiovascular disease. Therefore, the responsibility o f education 
and screening in an effort to reduce cardiovascular disease falls heavily on the primary 
care provider.
Research Questions
The purpose of the current research was to identify cholesterol screening 
practices o f primary care providers according to the NCEP ATP III guidelines. In 
addition, the current research sought to identify the cardiovascular disease risk factors 
present in patients who were screened and patients who were not screened using a 
fasting lipoprotein panel. The research questions were as follows:
1. Are primary care providers performing a fasting lipoprotein profile on 
patients between the ages o f 20 and 40 years once every 5 years?
2. Were risk factors present in the patients who had a fasting lipoprotein profile 
performed?
3. Were risk factors present in the patients who did not have a fasting 
lipoprotein profile performed?
Definition of Terms
For the purpose of the current research, the researchers defined the following 
terms with both operational and theoretical definitions. The operational definitions 
specify the operations that the researchers performed in order to collect and measure the 
required information. The theoretical definition specifies the abstract meaning of the 
concepts studied by the current research.
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Primary care providers
Theoretical'. The healthcare provider, namely a physician, nurse practitioner, 
physician’s assistant, or doctor of osteopathy, responsible for the healthcare and 
treatment o f a person (Venes, 2009).
Operational’. Physician or nurse practitioner providing care to the patients o f the 
clinics included in the current research.
Fasting lipoprotein profile
Theoretical'. A fasting lipoprotein panel that provides measurements of an 
individual’s total cholesterol, high-density lipoprotein, low-density lipoprotein, and 
triglyceride levels present in the blood. The test is performed with the patient 
abstaining from all food and drink, excluding water, for 8-12 hours prior to blood draw 
(Venes, 2009).
Operational. A blood test performed on venous blood used to identify total 
cholesterol, high-density lipoprotein, low-density lipoprotein, and triglyceride levels 
present in the blood of a patient who has abstained from food and drink, excluding 
water, for at least 8-12 hours prior to blood draw.
Patients
Theoretical. An individual receiving medical care (Venes, 2009).
Operational. Persons between the ages of 20 and 40 years receiving care in the 
clinics included in the current research.
Risk factors
Theoretical. An environmental, chemical, psychological, physiological, or 
genetic element that predisposes an individual to the development of a disease (Venes, 
2009).
Operational: Factors that increase a patient’s risk of developing cardiovascular 
disease including tobacco use, hypertension, hyperlipidemia, obesity, and a family 
history of cardiovascular disease.
Assumptions
The assumptions presumed by the researchers during the current research are 
listed below:
1. Primary care providers are adhering to and familiar with current cholesterol 
screening guidelines presented in the NCEP ATP III guidelines regarding 
screening recommendations in adults between the ages of 20 and 40 years.
2. Primary care providers are identifying risk factors associated with 
cardiovascular disease in each patient including tobacco use, high blood 
pressure, obesity, and family history o f cardiovascular disease.
3. Screening for cholesterol is a health-promoting behavior that is beneficial to 
the patient’s cardiovascular health and overall wellness.
4. All data related to the patient, including age, sex, and payer information, are 




A comprehensive review of literature pertinent to the current research is 
presented in this chapter. The current research investigated the cholesterol screening 
practices o f patients between the ages of 20 and 40 years in primary care. The purpose 
of the review of literature was to provide a background detailing how prior studies have 
influenced the current research. Several articles were included because they provide 
evidence of screening disparities between younger adults and older adults. Other 
articles are presented because they provided a background o f cardiovascular disease risk 
factors, which are often present in patients with hyperlipidemia. These articles 
influenced the current study while the researchers developed the data collection tool 
utilized during chart reviews in the five respective clinics.
Conceptual Framework
When choosing a conceptual framework to guide research, it is logical to review 
past studies that have applied Nola Pender’s Health Promotion Model to research. 
Alkhalaileh, Khaled, Baker, and Bond (2011) conducted a study in order to review how 
Nola Pender’s Health Promotion Model (HPM) has been used in prior research studies. 
Pender’s theory, developed in 1982, is centered on helping individuals gain higher 
levels of well-being. Health promotion is widely used by primary care providers via 
signs, posters, and ads encouraging the population to eat well, exercise, and use 
preventative measures, such as vaccinations. Nola Pender’s HPM not only encourages 
illness prevention but also encourages individuals to seek ideal health-promoting 
behaviors. This theory is commonly used throughout the nursing world, especially in 
the primary care setting.
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The intent of Alkhalaileh et al. (2011) was to evaluate how Nola Pender’s HPM 
has been utilized in other research studies. The HPM is widely accepted in the nursing 
field. It is used in accordance with nursing care, research, and education. Alkhalaileh 
et al. (2011) measured the types of studies guided by the HPM, as well as the different 
populations and settings included in the studies reviewed.
The methodology of the study by Alkhalaileh et al. (2011) consisted of an 
electronic computer search for research studies guided by the HPM. The databases used 
for the search included Medline, CINAHL, PsychoINFO, and the British Nursing Index. 
The keywords Pender’s and Health Promotion Model were used in the search. 
Alkhalaileh et al. (2011) reviewed the abstracts o f 37 articles. Twenty-six of these 
articles were excluded as they were non-research-based or were not published in a peer- 
reviewed nursing journal. After reviewing the abstracts, 11 research studies were 
retrieved in order to review how the HPM guided the studies reviewed by Alkhalaileh et 
al. (2011). The research studies met the following criteria and were included in the 
study performed by Alkhalaileh et al. (2011):
1. The article was published in a peer-reviewed nursing journal.
2. The HPM was the conceptual framework or one of the conceptual 
fi*ameworks that guided the study by Alkhalaileh et al. (2011).
3. The article was research-based; full text article was present; and article was 
published in English language.
4. The articles were published between 2002 and 2010.
Among the 11 research studies used, nine of the studies utilized quantitative 
research methodologies. One of the 11 studies used a qualitative methodology, and 
another study was secondary analysis. Alkhalaileh et al. (2011) found the purposes of
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the reviewed studies had a wide variation. They divided the purposes o f the reviewed 
studies into two categories. The first category included the studies that described 
aspects of the HPM in different populations, while the second category included the 
studies that tested relationships either among different variables of the HPM or between 
selected HPM variables and other variables (Alkhalaileh et al., 2011). A multitude of 
populations were included in the reviewed studies, such as workers, pregnant women, 
homeless women, adults with chronic diseases, and HIV/AIDS patients. The variables 
discussed in the reviewed studies included health-promoting behaviors, perceived 
benefits to action, self-efficacy, social support, and self-esteem. The reviewed studies 
discussed how the concepts of the HPM related to the variables discussed. In the 
reviewed studies, the self-report method was used as a data collection method. Self­
administered questionnaires were used in the majority o f the reviewed studies; however, 
some used interviews for data collection while others used techniques, including 
observation, lab tests, and blood pressure measurements. Measuring instruments used 
in the reviewed studies included Pender’s Health-Promoting Behavior Scale, Pender’s 
Commitment to a Plan o f Action Scale, Pender’s Perceived Barriers to Action Scale, 
and Pender’s Preference Scale (Alkhalaileh et al., 2011).
Because the studies reviewed by Alkhalaileh et al. varied widely in the settings 
and populations, the results varied widely as well. However, the results of each 
reviewed study indicated improvement in overall compliance and health-promoting 
behaviors among the individuals involved. One study’s results showed health- 
promoting behaviors and self-esteem had a direct effect on quality o f life, while another 
study showed that the HPM influenced a group of Korean adults with cardiovascular 
disease (CVD) to commit to a plan of exercise. Alkhalaileh et al. (2011) revealed the
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correlation between Pender’s HPM and health-promoting behaviors. Alkhalaileh et al. 
(2011) also depicted how the HPM can be used in varying nursing situations and as a 
framework for research-based work.
Preventative screening is a key component to health-promoting behavior for 
providers and patients alike. Alkhalaileh et al. (2011) showed how Pender’s model can 
be applied to research, such as the current research of cholesterol screening measures.
As advanced practice nurses, it is important to understand how the HPM was utilized in 
the current research study and how it can be utilized in practice. Preventative practices, 
such as cholesterol screenings, are imperative in the primary care setting. Primary care 
providers perform cholesterol screenings to aid in the prevention of cardiovascular 
disease. Integrated reviews, such as the current research, are required in order to reveal 
how theories (e.g., the HPM) influence and benefit nursing policy and practice.
Pender’s HPM was also used as the theoretical framework for Vakili, Rahaei, 
Nadrian, and YarMohammadi (2011), who conducted research on the predictors of oral 
health behaviors to identify variables that may be altered through intervention. Vakili et 
al. (2011) emphasized the importance of oral health by stating its importance to overall 
health and education. Children with poor dentition are more likely to underperform in 
school and accrue more absences. Gum disease is stated as more prevalent in older 
children, adolescents, and adults. This is o f much concern since the Islamic Republic of 
Iran has a population of more than 70 million people. The dentist-to-citizen ratio is 
largely outnumbered, with one dentist to every 5,500 people. A complex mix of 
different influences determines the overall outcome of oral health behavior. These 
factors include biological, social, economic, cultural, and environmental factors, 
knowledge, and attitudes to health and learned behavior, as well as access to health
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services. Vakili et al. (2011) stated that Pender’s HPM is one of the explanatory 
nursing models that predict health behavior.
Vakili et al. (2011) attempted to answer the following four questions central to 
their research:
1. What is the pattern of performing oral health behaviors in the students in a 
developing country, like Iran?
2. In what aspects o f oral health behaviors do students report having 
difficulties?
3. To what extent do the variables of the Health Promotion Model predict 
performing oral health behavior of the students?
4. May the Health Promotion Model be used in a developing country, like Iran, 
as a framework for planning intervention programs to improve the oral 
health behaviors of students?
Vakili et al. (2011) gathered information from 320 high school students from 
four high schools in Shahrekord City, Iran. The students were provided questionnaires 
that were kept confidential. Twenty students did not consent to the questionnaire; 
therefore, 300 students (140 males and 160 females) completed the questionnaires. 
Vakili et al. (2011) developed a system to measure the pattern o f oral health. The two- 
scale plan, a commitment to a plan of oral health, assessed if  the subjects had a regular 
plan to brush their teeth. A yes response was scored a one, and a no response was 
scored a zero. If  the subject answered y for the first question, they were asked how 
often they were committed to implement their plan of action. Vakili et al. (2011) used a 
3-point Likert scale for the answer to the second question. A score of 0 was given for
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not at all, a 1 for somewhat, and 2 for completely. Higher scores indicated a greater 
commitment to a plan of oral care.
The phrasing of the questions was considered important; therefore, a panel of 
seven experts which included a health behavior specialist, an educator, a dentist, and an 
oral healthcare provider reviewed the questions. The internal consistency o f design was 
assessed using a pilot study of 30 students. Cronbach’s coefficient alpha was used to 
estimate the internal consistency. The results were not published in the final sample. 
Vakili et al. (2011) also collected age, gender, and parents’ education level as 
demographic data.
The statistical data were computed using the Statistical Package for the Social 
Sciences (SPSS). The HPM variables were calculated using t test and one-way 
ANOVA. The percentages o f oral health behavior in high school students were as 
follows: tooth brushing (49.3%), using dental floss (15.3%), visiting a dentist twice a 
year (7%), and using a fluidized oral irrigator (5.3%). It was also found that the 
parents’ education level coincided with the performance of oral health behaviors. The 
higher the parental education level, the more likely a child was to perform oral care. 
Pearson’s analysis found a positive correlation between the HPM variables and oral 
health. The HPM variables had a positive correlation because the parents proved to be 
the most important influence in oral health behaviors o f the students. The positive 
correlation of parental education and oral performance behavior suggested that the more 
educated parents were more involved and proved to be better interpersonal influences. 
Vakili et al. (2011) stated that oral health providers should consider this fact and focus 
on a design centered on interpersonal modeling.
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Vakili et al. (2011) also found that females had a better performance of oral 
health than male subjects. Vakili et al. (2011) stated that one way to enhance oral care 
in the male population would be to use females as role models in oral health promotion. 
This design should include providing individual instruction practices and information 
through self-help groups. The students’ self-efficacy should also be a main focus. By 
giving students adequate information and providing them with positive feedback, which 
may enhance their confidence in the given task, the students should exhibit better oral 
health behaviors. Other methods which may have a positive effect on oral health 
included guided exercise of a new skill, setting short-term goals, and combining 
feedback about accomplishments, modeling, and social support.
The study by Vakili et al. (2011) is appropriately similar to the current research. 
The study by Vakili et al. (2011) selected Pender’s HPM to determine the oral health 
behaviors among high school students in Iran. The current research used the same 
model to determine the cholesterol screening practices of primary providers in a 
southeastern state. Though these two studies differ in population and variables, the 
current researchers were able to study these data and make similar assumptions based 
on a similar model. For example, the study by Vakili et al. (2011) determined that self- 
efficacy, an individual’s belief in his or her capacity to execute certain behaviors, 
played a major part in the oral health behaviors in Iran. Therefore, an emphasis should 
be placed on the primary care provider’s self-efficacy when determining which patients 
are being selected for cholesterol screenings.
Ronis, Hong, and Lusk (2006) conducted a quantitative study comparing the 
usefulness of Nola Pender’s original HPM against her revised HPM. The HPM is a 
valuable and popular theoretical framework utilized in nursing research. Its foundation
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draws from the expectancy value and the social cognitive theories. Following its initial 
publication in 1982, the Health Promotion Model has been used in countless studies. 
However, research found limitations to the model. Therefore, in 1996 Pender 
introduced a revised HPM model which dropped some variables, added others, and 
stressed new importance of some of the original model’s variables. The revised HPM 
was identified as the theoretical framework in the study performed by Ronis et al. 
(2006).
The purpose of the study performed by Ronis et al. (2006) was to compare the 
ability o f the original HPM model with the ability of the revised HPM model to predict 
a behavioral outcome. In addition, Ronis et al. (2006) sought to determine if  placing 
importance on the variables of interpersonal and situational influences and behavior 
factors, according to the revised HPM, improves the revised model’s ability to predict a 
health-promoting behavior.
Ronis et al. (2006) utilized data collected from an interventional study that 
sought to uncover whether a construction worker’s use of ear protection in noisy areas 
would improve after being educated on the importance of ear protection. Ronis et al. 
(2006) performed secondary analyses of the data. The population included two groups: 
(a) one that represented only construction workers from the Midwest and (b) another 
that included workers from across the United States. The respective sample ( # =  703) 
only consisted of construction workers in noisy areas of a construction site. The sample 
of workers included differing trades (e.g., carpenters, operating engineers, 
plumbers/pipefitters, and plumber/pipefitter trainers) (Ronis et al., 2006).
Ronis et al. (2006) distributed a posttest, self-reported questionnaire to the study 
participants. Multiple reliable scales in the questionnaire were utilized to quantify each
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HPM’s variable, including (a) demographic characteristics, (b) interpersonal influences, 
(c) situation factors/influences, (d) perceived control o f health, (e) definition of health, 
(f) perceived hearing health status, (g) perceived self-efficacy, (h) perceived benefits, (i) 
perceived barriers, and (j) exposure to the intervention. Finally, the questionnaire asked 
the participant whether or not the educational series affected the likelihood of wearing 
ear protection (Ronis et al., 2006).
Results of the questionnaire were analyzed utilizing EQS matrix and 
Confirmatory Factor Analysis (CFA). The CFA measured whether or not the variables 
correlated to the behavioral outcome of wearing ear protection. Three separate CFA 
analyses were performed in an attempt to make data more usable.
Data collected offered valuable insight into the HPM, The revised HPM 
structure performed superiorly to the original model as evidenced by a 28% predictive 
variance rate by the revised HPM compared to only an 18% predictive variance rate by 
the original model. This finding can be attributed to the revised version placing greater 
importance on allowing behavior specific factors to have a direct and indirect path to a 
behavioral outcome. Factors that were dropped from the original HPM including 
perceived control o f health proved to be a weaker factor in predicting health-promoting 
behavior. The findings o f Ronis et al. (2006) supported the restructured HPM and the 
idea that it was more accurate in predicting health-promoting behaviors. Therefore, the 
revised HPM was utilized in the current research.
Review of Related Research
The National Cholesterol Education Program Adult Treatment Panel III (NCEP 
ATP III) guidelines, developed by the National Institutes o f Health, recommend 
performing a fasting lipoprotein panel on all adults every 5 years, beginning at 20 years
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of age. The following review of past research highlights disparities in the screening of 
young adults for dyslipidemia and other cardiovascular risk factors.
The leading cause of death in the United States is coronary heart disease 
(CHD). Dyslipidemia is a leading risk factor in the development of CHD and can begin 
to develop in early adulthood (CDC, 2014a). Barham et al. (2009) conducted a 
randomized practice-based trial to observe the frequency of lipid screenings and 
appropriate management in a sample of North Carolina primary care practices. Barham 
et al. (2009) stated that dyslipidemia is an important aspect to study due to its 
association with CHD, which is the leading cause of death in the United States (Barham 
et al., 2009). The appropriate treatment for dyslipidemia may also reduce the risk o f 
CHD by 30% (Barham et al., 2009). Barham et al. also stated that CHD affects women 
and racial and ethnic minorities disproportionately. The study by Barham et al. (2009) 
set out to determine whether patient-level differences, such as sex, ethnicity, and 
cardiovascular disease, are associated with disparities in lipid screening.
Barham et al. (2009) gathered information from 61 community practices, 
teaching hospitals excluded, from June 1, 2001, through May 31, 2003. The practices 
were analyzed according to the NCEP ATP III along with demographics, cholesterol 
values, and comorbid conditions which were abstracted from the records. Eligible 
patients included those between the ages of 21 and 84 years who were not currently 
taking lipid-lowering therapy.
Barham et al. (2009) used a multivariable logistic regression model to determine 
if  age, sex, race/ethnicity, diabetes, cardiovascular disease, NCEP ATP III risk 
category, or pretreatment of low-density lipoprotein had an effect on treatment. Since 
the research involved quality improvement, individual patient consents were not
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required. Privacy was concealed under Health Insurance Portability and Accountability 
Act (HIPAA), Nurse abstractors collected data using a standardized data collection tool 
on a laptop computer on-site. Barham et al. (2009) then divided the patients into three 
categories: (a) patients taking lipid-lowering therapy prior to June 1, 2001, (b) patients 
not taking lipid-lowering therapy prior to and without lipid screening data during the 
data collection period, and (c) patients not taking therapy prior to June 1, 2001. The 
first category was eliminated because it focused more on therapy management than 
initial decision-making. The second and third categories were further subdivided into 
demographics and comorbidities. The demographics category consisted of age, sex, and 
race/ethnicity. The comorbidities category of CHD and diabetes. Evidence of attempts 
to correct their LDL with lifestyle changes was indicated also as a therapeutic lifestyle 
category (Barham et al. (2009).
Screened patients were then placed into categories determined by their NCEP 
ATP III risk category. A number from 1 to 4 was assigned and was based on the 
following guidelines: (a) low risk (0 or 1 risk factor for CHD), (b) intermediate low-risk 
(> 2 risk factors) and Framingham risk score (FRS), a 10-year risk of having a heart 
attack < 10%), (c) intermediate high risk (> 2 risk factors and FRS > 20%), and (d) 
high-risk (CHD risk equivalent and or > 2 risk factors and FRS > 20%.
A total o f 5,742 charts were examined from the 61 primary care practices.
More than half o f the patients had a pretreatment LDL <130 mg/dl and only 5% had an 
LDL of at least 190 mg/dl. One third of the patients were placed into the low-risk 
category, and 25% was placed into the high-risk category. The total screening rate was 
34.5%, which follows closely with the NCEP ATP III goal of 40%. O f the 1,711 
patients, 1,310 were appropriately managed. Barham et al. (2009) concluded that
21
screening rates were higher at older ages, but the appropriateness o f treatment was 
lower at older ages. There were no large discrepancies seen amongst the sexes and 
ethnicities. Patients with diabetes were more likely to be screened but less likely to 
receive appropriate treatment than patients without the disorder. The category which 
received the most appropriate treatment was the low-risk category with an LDL of <
130 mg/dl.
In conclusion, the findings indicated that patients at high risk for CVD are at the 
greatest risk of being undertreated for dyslipidemia per NCEP ATP III guidelines.
Also, older individuals are more likely to be screened but less likely to be appropriately 
treated. Barham et al. (2009) stated that their findings were consistent with an analysis 
o f a Multi-Ethnic Study of Atherosclerosis, which states that higher risk individuals 
were more likely to be undertreated. Barham et al. also stated that screening by age 
seems to reflect a provider’s belief that a younger, seemingly healthier individual may 
not necessitate screening due to their low risk of CVD. Efforts should be taken to 
improve the screening and management o f intermediate to high-risk patients.
The study performed by Barham et al. (2009) was appropriately similar to the 
current research investigation into primary care lipid screenings and provided a strong 
foundation for the current research. The current research was obtained fi*om a sample 
of 100 charts from five primary care facilities, much smaller than the sample compiled 
by Barham et al. which sampled 61 facilities and 5,742 charts. Yet, it still offers 
considerable insight into the statistics o f screening patterns in a primary care setting. 
Also, the current research questions coincided with Barham et al. (2009) by analyzing if 
primary care facilities are abiding by guidelines when screening for cholesterol.
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Kuklina, Yoon, and Keenan (2010) conducted a study in order to measure the 
compliance of cholesterol screening guidelines among the young adult population. 
High-cholesterol levels are one of the main risk factors for CHD, a leading cause of 
mortality in men and women in the United States (CDC, 2014a). Kuklina et al. (2010) 
utilized the measurements found in their study to determine if primary care providers 
are compliant in screening for high-cholesterol levels in young adults (men aged 20 to 
35 years, women aged 20 to 45 years), as recommended by the NCEP ATP III 
guidelines. These guidelines are endorsed by the American Heart Association and the 
National Heart, Blood and Lung Institute, and recommend screening for high- 
cholesterol levels every 5 years in adults age 20 years and older.
The purpose of the study by Kuklina et al. (2010) was to determine whether or 
not young adults are being screened for high-cholesterol levels, as recommended by the 
NCEP-ATP III guidelines. Kuklina et al (2010) stated three objectives in their study:
(a) the proportion o f persons with CHD, CHD equivalents, or CHD risk factors; (b) 
rates of the self-reported screening for high cholesterol performed before the study; and 
(c) the prevalence of high low-density lipoprotein (LDL) levels that had been assessed 
by a fasting lipid test during the National Health and Nutrition Examination Survey 
(NHANES) (Kuklina et al., 2010). The CHD equivalents were defined as other forms 
of atherosclerotic vascular disease, diabetes, or risk o f CHD > 20% within 10 years. 
Other CHD risk factors were defined as smoking, hypertension, familial history of early 
CHD, and obesity.
The study participants included those surveyed by NHANES. The NHANES 
uses a complex, multistage probability design to select participants in order to survey 
the health and nutritional status of the U.S. civilian, noninstitutionalized population
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(Kuklina et al. 2010). Approximately 6,000 participants are selected each year to 
participate in the study. The data are released in 2-year increments. For the purposes of 
Kuklina et al.’s study, data were obtained from the four most recent cycles: 1999-2000, 
2001-2002, 2003-2004, and 2005-2006. A group of 13,875 participants were randomly 
selected for fasting laboratory testing of cholesterol levels. After excluding those 
participants younger than 20 years o f age, men older than 35 years of age, women older 
than 45 years o f age, and women with a positive urine pregnancy test and/or reported 
pregnancy, Kuklina et al. (2010) was left with a sample size o f 2,587 participants.
The participants were further sub categorized by sociodemographic 
characteristics (i.e., gender, race/ethnicity, education, and poverty index) and CHD risk 
factors (i.e., number o f times the participant received healthcare in last the 12 months), 
history of CHD or CHD equivalent, positive for CHD risk factors (e.g., hypertension, 
smoking, obesity, family history o f CHD), were taking lipid-lowering medication. 
Screening percentages were also obtained based on the number o f risk factors for CHD 
among the participants and the prevalence o f high LDL levels by the number of risk 
factors among participants.
The results o f the study by Kuklina et al. (2010) showed that 63% of young 
adults (men aged 20 to 35 years, women aged 20 to 45 years) with CHD or CHD 
equivalent, 26% of young adults with two or more risk factors, 12% o f young adults 
with one risk factor, and 7% with no risk factors had a high low-density lipoprotein 
(LDL) level (Kuklina et al., 2010). Except for persons with CHD or a CHD equivalent, 
screening was found to be low in young adults (about 50% for women and < 40% for 
men). Kuklina et al. (2010) found no significant difference in the screening rates 
between young adults with no risk factors and those with one or more risk factors, even
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after adjusting for sociodemographic and healthcare factors. The low screening rates in 
the young adults with two or more risk factors were alarming, considering the risk for 
CHD rises with each occurring risk factor. Kuklina et al. (2010) recommended that 
future studies be done to identify how cholesterol screening among young adults could 
be improved in primary care settings. Their results also support the need to improve 
assessment and management o f cardiovascular disease risk factors among young adults.
This study overall applies to the current research. Kuklina et al. (2010) focused 
on the compliance, or lack thereof, o f high cholesterol screening in young adults, basing 
their participant groups on the NCEP ATP III guidelines, which are the same guidelines 
the current research has built a foundation upon. Kuklina et al. (2010) offered 
methodology variables for the current research, broadening the sociodemographic 
characteristics, and also assisted the current research in adjusting for variables such as 
CHD risk factors.
Cardiovascular disease has been found to be the third leading cause of death in 
women 18-44 years o f age (Robbins et al., 2013). Robbins, Dietz, Cox, and Kuklina
(2013) sought to identify the prevalence of risk factors in women of reproductive age 
according to the American Heart Association (AHA) at-risk definitions versus United 
States Preventative Serve Task Force (USPSTF) at-risk definitions. For women, risk 
factors, such as dyslipidemia, or abnormal cholesterol levels, precede cardiovascular 
diseases, such as heart attack and stroke. Dyslipidemia is also associated with polycystic 
ovarian syndrome, atherogenesis, and heart disease in women. With cardiovascular 
disease being a leading cause of mortality in adult women, it is important to identify 
women at risk by determining which risk factors, such as dyslipidemia, are present.
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Robbins et al. (2013) utilized the AHA and USPSTF risk definitions to determine the 
proportions o f women at risk according to each set of risk criteria.
Robbins et al. (2013) sought to compare at-risk definitions between the AHA 
versus the USPSTF. The population sample consisted of 1,781 women with data being 
drawn from the NHANES fi*om the years 2007-2008. Physical examinations and labs 
were performed and questionnaires administered in mobile examination centers. Binary 
variables were created for CVD risk status, measures of dyslipidemia, and 
sociodemographic characteristics. USPSTF risk factors included diabetes, 
hypertension, tobacco use, obesity, and family history of CVD. AHA risk factors were 
defined as chronic kidney disease, pre-hypertension/hypertension, central obesity, poor 
diet, physical inactivity, history o f gestational diabetes mellitus, rheumatoid arthritis, 
and Framingham 10-year CVD risk > 10%. Sociodemographic characteristics were 
age, race/ethnicity, education, and annual family income.
The Stata Software Version 11 was used to conduct data analyses. Since the 
risk of developing dyslipidemia increases with age, differences in distributions of CVD 
risk factors by age were assessed using Pearson chi-square tests {p < .05) with Rao and 
Scott second-order corrections. The prevalence of dyslipidemia was calculated by risk 
category and stratified by risk and age category. Dyslipidemia prevalence and case-to- 
screening ratio were estimated by dyslipidemia type among women at-risk according to 
the AHA guidelines but not at-risk according to the USPSTF guidelines.
Robbins et al. (2013) found that nearly all women, whether of reproductive age 
or older, had at least one risk factor according to the AHA guidelines, with unhealthy 
diet being significant in the younger and older population. High prevalence of 
dyslipidemia was reported among women of reproductive age, and over half had not
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had a cholesterol screening within the previous 5 years. Robbins et al. (2013) identified 
a much higher prevalence of CVD risk in the sample population when using the AHA 
guidelines set forth by the NCEP ATP III guidelines versus using the USPSTF 
guidelines. Robbins et al. (2013) also determined that future studies were needed to 
assess whether identification and treatment of all women with dyslipidemia will 
decrease CVD mortality later in life.
Robbins et al. was pertinent to the current research from different aspects. First, 
Robbins et al. (2013) utilized AHA at-risk definitions, which are based upon the NCEP 
ATP III guidelines that served as the foundation for the current research. Also, Robbins 
et al. (2013) magnified the prevalence of dyslipidemia and other CVD risk factors in 
women of reproductive age. In the research performed by Robbins et al. (2013), nearly 
99% of the sample population was positive for at least one CVD risk factor according to 
the AHA at-risk definitions. Robbins et al. (2013), along with the current research, 
highlighted the importance of identifying risk factors o f CVD, such as dyslipidemia, 
and treating each risk factor accordingly in hopes to prevent future disease.
It is important to recognize that the development of high-cholesterol levels and 
associated risk factors of cardiovascular disease may develop earlier than 20 years of 
age, which could contribute to cardiovascular disease in adulthood (CDC, 2012). May, 
Kuklina and Yoon (2012) conducted a study in order to measure recent trends in the 
prevalence of certain biological risk factors of cardiovascular disease in adolescents. 
Moreover, May et al. (2012) measured the prevalence of these risk factors in 
adolescents who were classified as either overweight or obese versus normal weight. 
CVD is a leading cause of mortality in the United States. Manifestations o f CVD, such 
as heart attack or stroke, typically do not appear until adulthood. However, risk factors
27
for these diseases, such as elevated cholesterol, hypertension, and diabetes, can appear 
in childhood and adolescence. May et al. (2012) was conducted in order to determine 
the trend of rising numbers o f adolescents with CVD risk factors, particularly those who 
are overweight or obese. Because these risk factors can transcend into adulthood, it is 
important to understand which adolescents are at risk for developing CVD and how to 
screen appropriately.
The purpose of the study by May et al. (2012) was to determine the prevalence 
o f CVD risk factors to include prehypertension/hypertension, borderline-high/high low- 
density lipoprotein (LDL) levels, low high-density lipoprotein (HDL) levels, and 
prediabetes/diabetes by weight status and their trends among adolescents aged 12 to 19 
years. May et al. objectively determined the trends of CVD risk factors among 
adolescents classified as normal weight, overweight, or obese.
The initial sample data were from NHANES, a nationally representative, 
continuous cross-sectional survey of the health and nutritional status of the U.S. 
civilian, noninstitutionalized population (May et al., 2012). Participants are selected 
annually to participate by using a complex, multi-stage probability design. The 
NHANES data are released in 2-year increments. The study by May et al. (20102) was 
conducted with data from 5 cycles: 1999-2000, 2001-2002, 2003-2004, 2005-2006, and 
2007-2008. The initial combined sample from the five cycles included 10,397 
adolescents. O f this group, 4,174 were randomly selected to provide fasting blood 
samples for lipid and glucose testing (May et al., 2012). Excluded were those who 
reported being pregnant or were missing data. The final sample included 3,383 
adolescents. May et al. (2012) defined overweight and obesity according to the CDC 
age and gender-specific percentiles for body mass index (BMI). May et al. defined
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overweight as having a BMI > 85th percentile and < 95th percentile. Obesity was 
defined as having a BMI > 95th percentile. Normal weight was defined as having a 
BMI > 5th percentile and < 85th percentile. Adolescents measured as underweight were 
not included in the study. Prehypertension and hypertension were measured and 
defined according to the average of three blood pressures taken during the physical 
examination portion of the study. In order to define prehypertension and hypertension 
in adolescents aged 12 to 17 years, May et al. (2012) used the guidelines established by 
the NHLBI that were specific for age, gender, and height. For participants 12 to 17 
years of age, prehypertension was defined as having a systolic blood pressure or 
diastolic blood pressure reading that was > 90th percentile and < 95th percentile. 
Hypertension was defined as having a systolic blood pressure or diastolic blood 
pressure reading > 95th percentile.
Prehypertension for study participants aged 18 to 19 years was defined as having 
a systolic blood pressure (SBP) of 120-139 mmHg or a diastolic blood pressure (DBP) 
of 80-89 mmHg. Hypertension for 18- to 19-year-olds was defined as having a SBP > 
140 mmHg or a DBP > 90 mmHg. Abnormal lipid levels in the study participants 
included borderline high low-density lipoprotein (LDL), high LDL, and low high- 
density lipoprotein (HDL) levels. May et al. (2012) used guidelines set by the NCEP 
ATP III in order to determine these levels. Borderline high LDL levels were those >
110 mg/dL to < 129 mg/dL. High LDL levels included >130 mg/dL. HDL levels < 35 
mg/dL were considered low. Prediabetes and diabetes were defined using guidelines set 
by the American Diabetes Association. Prediabetes was defined as having a fasting 
plasma glucose level > 99 mg/dL to < 126 mg/dL. Those adolescents who had a fasting 
glucose >126 mg/dL were classified as having diabetes. Demographic characteristics
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included gender, age, and race/ethnicity. These characteristics were self-reported 
during the home interview by NHANES. Ethnicity included non-Hispanic white, non- 
Hispanic black, Hispanic, and other. May et al. (2012) began data analysis by 
measuring each BMI category to include normal weight, overweight, and obese. Next, 
May et al. measured the proportion of adolescents with one of four CVD risk factors for 
the entire sample, followed by measuring based on BMI category. Next, May et al. 
(2012) measured the differences in prevalence of each of the four CVD risk factors, as 
well as of overweight and obesity, across the five-study cycles. Finally, May et al. 
(2012) measured combinations of two or more of the four CVD risk factors among 
overweight and obese adolescents and clustered their findings based on prevalence.
May et al. (2012) found that 34% of the study group was overweight or obese. 
The overall prevalence for each of the four risk factors was > 10% with the exception of 
low HDL (May et al., 2012). Borderline-high/high LDL was the most prevalent risk 
factor overall. A dose-response increase with weight category was observed for each of 
the four risk factors, with 49% of overweight and 61% of obese adolescents having at 
least one of the CVD risk factors. The most prevalent two-risk factor combination 
included prehypertension/hypertension and borderline-high/high LDL, which accounted 
for nearly one fourth o f the study sample. No significant differences were noted among 
the different ethnicities; however, the increase o f risk factor prevalence was 
substantially higher in those adolescents who were overweight or obese.
The basis of May et al.’s study was pertinent to the current research. The 
prevalence o f CVD in the U.S. is ever-growing. While CVD and its manifestations, 
such as heart attack and stroke, are still most likely to present in adulthood, healthcare 
professionals should seriously consider the prevalence of CVD risk factors in youth.
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The findings o f May et al.’s study indicated that the adolescent youth of the country 
bear a significant burden of risk factors for CVD. These findings are also concerning 
due to the fact that these risk factors most likely will carry over into adulthood. 
Borderline-high and high LDL levels were the most significant CVD risk factors found 
by May et al. (2012). It is imperative that advanced practice nurses adhere to current 
guidelines and screen for high cholesterol appropriately. It is evident in the study 
conducted by May et al. that high cholesterol and other CVD risk factors do not limit 
themselves to adults only; therefore, providers should be vigilant in beginning 
cholesterol screenings at the recommended age of 20 years.
Risk factor identification is an important step in primary prevention of 
cardiovascular disease. Johansen, Green, Sen, Kircher, and Richardson (2014) 
investigated the relationship between certain cardiovascular disease risk factors and the 
use of statin drugs. It is well documented that statins can significantly reduce a person’s 
risk of developing cardiovascular disease. However, past research has indicated statins 
are underutilized in patients with cardiovascular risk factors, diabetes, and 
cardiovascular disease.
The purpose of the study performed by Johansen et al. (2014) was to identify 
themes and correlations between the diagnosis o f cardiovascular disease and various 
cardiovascular disease risk factors with the use o f statin drugs. Additional research 
questions sought to identify each cardiovascular risk factor separately and its correlation 
to statin therapy utilization.
Johansen et al. (2014) utilized the 2010 Medical Expenditure Panel Survey 
(MEPS) to establish the respective sample for their study. Johnansen et al.’s population 
included all MEPS participants aged 30 to 79 years resulting in 16,712 individuals.
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Any subject within the population who was deemed ineligible for statin therapy was 
eliminated from the sample. Next, two different analysis groups were formed. The first 
group contained each member of the sample. The second group contained only 
members o f the sample with a history of diabetes mellitus or coronary artery disease. 
The independent variable was identified as a statin user (Johansen et al., 2014).
The dependent variables were identified as cardiovascular risk factors as 
follows: (a) hyperlipidemia, (b) coronary artery disease, (c) diabetes mellitus, (d) 
cerebrovascular disease, (e) peripheral artery disease, and (f) hypertension. A modified 
cardiovascular disease risk index was also utilized. The index was necessary for use in 
individuals who did not have a history of coronary artery disease or diabetes (Johansen 
et al., 2014).
In addition, sociodemographic covariates were identified. The covariates 
included the following: (a) age, (b) race, (c) poverty category, (d) tobacco use, and (e) 
insurance coverage. Age is an important factor in identifying cardiovascular risks 
because cardiovascular risk factors often increase with a person’s age. Insurance and 
poverty categories could serve as important covariates because they may identify a 
population at risk for statin noncompliance secondary to an inability to access or afford 
necessary healthcare (Johansen et al., 2014).
The data collected by Johansen et al. (2014) revealed several significant 
findings. First, the presence of hyperlipidemia proved to be the most significant risk 
factor in predicting statin use. Individuals who were diagnosed with hyperlipidemia 
were more likely to be on a statin than those individuals with cardiovascular disease or 
diabetes who did not have hyperlipidemia. Furthermore, high-risk individuals 
diagnosed with hyperlipidemia that did not have a history o f coronary artery disease or
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diabetes were being managed on statins more often than high-risk individuals who were 
not diagnosed with hyperlipidemia (Johansen et. al, 2014).
The study by Johansen et al. (2014) was relevant to the current research because 
the findings supported the need for examining primary care providers’ adherence to 
NCEP ATP III guidelines for cholesterol screening and management of patients. 
Johansen et al. (2014) found that many patients who were not diagnosed with 
hyperlipidemia were undermanaged. Under-management of such a significant risk 
factor puts patients at unnecessary risk for developing cardiovascular disease. This 
finding shows the importance of properly screening all patients for risk factors rather 
than hyperlipidemia alone.
The methodology utilized by Johansen et al. (2014) influenced the development 
of the data collection form for the current research. The current research also sought to 
identify whether the variations of age, payer source, or tobacco use correlated with 
cholesterol screening practices.
Research performed by Feinglass, Jean-Jacques, and Kenik (2014) investigated 
the relationship of racial and ethnic disparities in cholesterol screening practices. A 
quantitative, cross-sectional, and nonexperimental study was conducted to investigate 
whether racial and ethnic disparities in cholesterol screening persisted after making 
adjustments for socioeconomic status, access to care, and language barriers.
Feinglass et al. (2014) utilized the 2011 Behavioral Risk Factor Surveillance 
System (BRFSS), monitored by the CDC, to collect data. The BRFSS is the largest 
ongoing telephone survey and utilizes a weighted ranking system. The system allows 
more demographic variables, such as age, gender, race, marital status, education, or 
home ownership. Sample parameters included men over the age of 35 years and
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women over the age of 45 years with increased risk for cardiovascular disease. 
Adjustments were made in the sample parameters to include all women over the age of 
45 years. The survey, conducted in 2011, questioned respondents as to whether they 
had ever had a cholesterol screen. Demographic factors were already calculated from 
the respondents’ information. Other categorizing factors included age, race, ethnicity, 
self-reported health status, household income, and personal doctor. Analysis o f data 
also factored in additional differences by race, ethnicity, younger respondents, smokers, 
higher income, and health insurance.
Feinglass et al. (2014) identified socioeconomic status, healthcare access, and 
language barriers as the fundamental elements contributing to the racial and ethnic 
disparities associated with lack of cholesterol screening. Out o f almost 13 million 
respondents, 9.1% reported never having a cholesterol screening performed (Feinglass 
et al., 2014). Additional findings revealed that the lack of health insurance and absence 
of a primary care provider also contributed to cholesterol screening disparities.
Feinglass et al. (2014) provided insight relevant to the current research because 
it defined and identified gaps in current cholesterol screening practices. Feinglass et al.
(2014) identified socioeconomic status, healthcare access, and language barriers as the 
primary elements contributing to the racial and ethnic disparities associated with lack of 
cholesterol screening.
With the implementation of the Affordable Care Act, Feinglass et al. (2014) felt 
that these issues would be resolved. Language barriers were also considered as an 
interfering factor, indicating the need to increase the availability o f bilingual primary 
care providers.
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The Coronary Artery Risk Development Study performed by Fletcher et al. 
(2010) provided valuable results and data supporting the current research. The purpose 
of the study performed by Fletcher et al. (2010) was to determine if  hyperlipidemia 
present in study participants between the ages o f 18 and 30 years was positively 
associated with the development o f CHD in the same participants 15 to 20 years later. 
Farticipants were represented from four cities across the United States. The participants 
were between the ages of 18 and 30 years at the time the study by Fletcher et al. (2010) 
took place.
The study by Fletcher et al. (2010) included 5,115 men and women. The 
participants were evaluated at years 2, 5, 7, 10, 15, and 20, respectively. At each visit, a 
fasting lipoprotein level was drawn. All labs were received and processed by one single 
laboratory located in Seattle, Washington. At year 15 or 20, a cardiac commuted 
tomography scan was performed to measure for the presence of coronary calcium.
In addition to drawing cholesterol levels, the variables o f age, sex, ethnicity, 
premature coronary heart disease risk, blood pressure, and tobacco use were recorded. 
When participants presented for the cardiac commuted tomography scan at year 15 or 
20, the variables o f education, income, fasting glucose level, diabetic status, BMI, and 
waist circumference, alcohol use, and activity level were also recorded. During the 
study analyses, these variants were analyzed to determine which variant had a positive 
correlation to the development of coronary calcium. In addition, analyses were 
performed to include and then exclude participants who were prescribed statin therapy.
The methodology further divided participants into the categories o f normal, 
borderline, or abnormal lipid levels during the time the participant was between 25 and 
35 years of age. The categories were defined by the low-density lipoprotein (LDL),
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high-density lipoprotein (HDL), and triglyceride cholesterol levels presented in the 
NCEP ATP III guidelines. These categories were used to calculate a correlation 
between abnormal cholesterol levels as a young adult to abnormal levels as a middle- 
aged adult and the presence of coronary calcium.
The data were analyzed using Spearman rank correlations and chi squares. At 
the time of analyses, 3,258 participants o f the original 5,115 were included. To be 
included, the participants must have had the coronary heart disease risk factor measured 
and results o f the cardiac commuted tomography (CT) scan. Fletcher et al. (2010) 
found that 47% of the participants were black, 42% were female, and an average of 42 
years o f age at the time of cardiac commuted tomography. Thirteen percent of 
participants were found to have an LDL <100 mg/dL, considered the optimal LDL 
measurement by the NCEP ATP III guidelines, throughout young adulthood. Seventy- 
five percent o f young adults were found to have non-optimal LDL levels.
The results o f the study by Fletcher et al. (2010) found a positive, strong 
correlation with increased lipid levels, specifically a high LDL and a low HDL, in 
young adulthood and the presence of hyperlipidemia and coronary calcium 15 to 20 
years later. O f the patients with an LDL o f 160mg/dL or higher during young 
adulthood, 44% were found to have coronary calcium present at the time of cardiac CT. 
The presence o f abnormal lipids was most commonly associated with the following 
demographics: white males, a higher than average income, a premature coronary heart 
disease risk, increased BMI and waist circumference measurements, diabetes, a 
sedentary lifestyle, and consumption of alcohol.
Even slight elevations in lipid levels showed an increased coronary calcium risk. 
Increased LDL and low HDL levels were the cholesterol measurements found to have
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the greatest impact on participants’ risk of developing coronary calcium. Patients who 
had a LDL level of 130-159mg/dL during young adulthood were 17% more likely to 
have coronary calcium on cardiac CT than those participants with optimal levels < 
lOOmg/dL. Furthermore, participants with a low HDL level in young adulthood 
experienced a statistically significant increase in the presence o f coronary calcium 15 to 
20 years later.
The findings o f Pletcher et al. (2010) supported the need for the current 
research. Young adults with even just a slight increase in LDL levels were at a higher 
risk for developing calcium in the vessels o f the heart than those young adults who kept 
LDL levels within the NCEP ATP III optimal level. Pletcher et al. (2010) provided 
evidence that activity level, diet, and lipid levels will impact the health o f young adults 
as they age. While heart disease is not considered a disease of the young, it begins to 
manifest itself silently in patients as young as 20 years of age. Analyzing cholesterol 
screening practices of primary care providers will shed light on how well young adults 
are being screened, managed, and educated on the importance of health-promoting 
behaviors that will leave a lasting impact on their lives as middle aged adults.
Parker et al. (2008) conducted a qualitative, ethnographic study investigating the 
perceived implementation barriers and facilitators felt by primary care providers toward 
the NCEP ATP III guidelines. When screening guidelines are introduced, the 
recommendations have been developed based on evidence and research to facilitate best 
practice. However, there tends to be an underwhelming compliance rate to screening 
guidelines in primary care. Parker et al. (2008) investigated what specific barriers 
primary care providers felt toward cholesterol screening and management guidelines 
introduced by NCEP ATP III guidelines.
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The purpose o f the study performed by Parker et al. (2008) was to identify 
barriers and facilitators primary care providers felt existed when implementing the 
NCEP ATP III guidelines. At the conclusion of their study, Parker et al (2008) hoped to 
gain insight into how their findings compared to previous research studies (Parker et al., 
2008).
After obtaining ethical approval from the Memorial Hospital o f Rhode Island 
Institutional Review Board, Parker et al. (2008) conducted nine separate focus groups. 
The focus groups were led and attended by a three-person research team who performed 
various roles. For example, an experienced primary care provider with a background in 
qualitative research guided the focus groups by utilizing prepared open-ended 
questions. The groups were conducted from October 2002 until February 2003 (Parker 
et al., 2008).
The population in the study performed by Parker et al. (2008) included 300 
primary care providers from various areas of Rhode Island. A sample o f 50 primary 
care providers participated in the focus groups. The characteristics o f the physician 
sample group included 68% males and 32% females, 52% specialized in primary care, 
while 44% practiced internal medicine. Ninety-two percent o f the sample had been in 
practice from 1 to 30 years. The focus groups were audio-recorded and performed until 
data saturation was achieved, which occurred during the seventh focus group. 
Redundancy was verified by performing the eighth and ninth focus group (Parker et al., 
2008).
Data were analyzed using activities common to qualitative research. First, the 
verbal and nonverbal messages were recorded from the researchers’ participation and 
observation immediately following each focus group. NVivo software and personal
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self-reflection and immersion into data were utilized by the researchers to code and 
categorize data. Finally, Parker et al. took part in 10 separate interpretation immersion- 
crystallization sessions (2008).
Three common themes related to guideline implementation were interpreted by 
researchers from the focus group data: physician-related, patient-related, and 
external/environmental issues. Key facilitators in adoption of the cholesterol screening 
guidelines included the following: (a) strong guideline credibility, (b) an improved 
awareness o f the importance of cholesterol management that providers felt patients 
were displaying, (c) technological advances, and (d) improved cost-effective screening 
tools. Barriers identified in implementing guidelines were as follows: (a) physician 
perceived guideline complexity, (b) lack of accessibility and guidance in guideline 
interpretation in rural practices, (c) patient noncompliance to provider recommendations 
and patient’s inability to afford guideline related tests or drugs, and (d) time constraints 
during patient encounters (Parker et al., 2008).
While Parker et al. (2008) were the first to look specifically at guidelines related 
to cholesterol, their results supported findings in previous guideline implementation 
studies. The findings o f Parker et al. (2008) supported the need for clinical prompting 
and decision-making software. The findings also verified that providers are willing to 
follow guidelines set forth by credible, evidence-based organizations. Furthermore, 
patient noncompliance or inability to follow doctor recommendations was identified in 
other studies.
Parker et al. (2008) was relevant to the current research. The research 
adequately identified barriers and facilitators of cholesterol guideline implementation, 
and its findings were congruent with prior research. The qualitative findings of Parker
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et al. (2008) provided valuable background and credible insight into the stated problem 
of the current research.
Summary
Performing a lipoprotein every 5 years in accordance with the NCEP ATP III 
guidelines promotes wellness and disease prevention. The HPM was discussed at 
length in the literature review. The HPM identified that patient wellness and positive 
health outcomes are directly related to whether a patient views a behavior as beneficial 
to his or her health. Patient health is influenced by a provider perceiving a behavior as 
beneficial and educating patients on a health behavior. The desired health behavior in 
the current research was cholesterol screening.
Overall, the studies reviewed for this chapter were significant in many ways.
For example, it was noted that barriers exist among providers when adopting guidelines 
(Parker et al., 2008). The literature review also revealed that 61% o f young adults 
possess at least one risk factor, such as obesity and a positive cardiac disease family 
history, that have proven to contribute to the development o f cardiovascular disease 
(May et al., 2012). Risk factors that were included in the research performed by 
Johansen et al. (2014) were included in the researcher-developed data worksheet 
compiled for the current research. The use o f this data collection worksheet aided the 
researchers o f the current study in identifying provider compliance to cholesterol 
screening guidelines. The results also identified possible risk factors and patient 
demographics, including age, sex, payer source, family history of cardiovascular 
disease, obesity, tobacco use, hypertension, or use of hypertensive medications, which 
may correlate with an increased or decreased chance of being screened. In addition, the
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current research identified whether the number of risk factors present influenced the 




Heart disease and stroke are the two leading causes of death in the United States 
(Centers for Disease Control and Prevention [CDC], 2014a). High-blood cholesterol is 
one of the main risk factors for CVD and is a prevalent problem in the United States 
(CDC, 2013). The National Cholesterol Education Campaign recommends that patients 
20 years of age and older be screened for high-blood cholesterol. The purpose of the 
current research was to determine whether or not primary care providers were adhering 
to the National Cholesterol Education Program ATP III (NCEP ATP IIII) guidelines for 
cholesterol screening of patients between the ages o f 20 and 40 years. Research design, 
setting, population, and methods of data collection are described in this chapter. 
Research Design
The current research consisted of a quantitative, descriptive, retrospective chart 
review to evaluate adherence to the NCEP ATP III guidelines by primary care 
providers. Data were obtained from a convenience sample o f 500 charts from a 
retrospective chart review. The research design was appropriate to address the research 
questions for the current research and also allowed the researchers to review screening 
behaviors o f practitioners without influencing them in order to yield results that were 
consistent with their normal practices.
Setting
The setting for the current research was five primary care clinics in the 
southeastern United States. Each o f the selected clinics provides primary care serves a 
diverse population, primarily Caucasian, African Americans, Hispanic, and Native 
American races, with ages ranging from pediatrics to the older adult.
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Clinic One is a federally funded rural community health center, staffed by one 
physician and three nurse practitioners who treat approximately 280 patients per week.
A sliding fee schedule is provided for low-income and indigent patients. The clinic also 
accepts government program insurance and private commercial insurance.
Clinic Two is a hospital-owned internal medicine practice staffed with 11 
physicians and four nurse practitioners. Two o f the 11 physicians treat pediatrics. The 
patient population consists o f pediatrics to geriatrics with the largest percentage of 
clients being the older adult. Approximately 200 patients are seen each day in this 
urban city clinic. Commercial private insurance and government program insurance are 
accepted. If a patient is self-pay, a charity program is available; a fee is set based on the 
client’s income.
Clinic Three is an internal medicine practice. The practice is owned and 
operated by one medical doctor who has been in practice for nearly 40 years. The 
majority o f the patient population ranges from adolescent to older adult. The practice is 
located in an urban city and serves over 1,500 patients. This practice serves the 
community following a unique model. The facility does not accept commercial 
insurance or government programs; instead, each patient pays a flat fee. The fee covers 
the doctor visits and any fees associated with certain labs or procedures commonly 
performed in an internal medicine practice.
Clinic Four is a large multispecialty clinic that houses physicians and nurse 
practitioners of specialties, such as family practice, pulmonology, nephrology, internal 
medicine, and gastroenterology. The patient sample was collected from the internal 
medicine physician’s office records. This physician routinely treats 15 to 20 patients 
per day, ranging from 18 to 99 years o f age. All insurance types are accepted, with the
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main payer source being private insurance. An average of 80 patients are treated each 
week.
Clinic Five is a nurse-practitioner-owned clinic in a rural community. This 
clinic serves a range of patients from pediatrics to geriatrics and accepts all insurance 
types. The main payer source is comprised o f self-pay and private insurance. An 
average of 30 patients are treated on a daily basis.
Population and Sample
The population in the current research included men and women 20 to 40 years 
of age with different ethnicities and payer sources. The current research included 100 
charts randomly selected by each respective clinic’s secretary for a total of 500 charts. 
The age selection was based on the recommendations within the NCEP ATP III 
guidelines for age-related screening. The charts selected included men and women 
between the ages of 20 and 40 years. These charts were reviewed for adherence to the 
NCEP ATP III guidelines. The 500 charts were further reviewed for certain 
cardiovascular risk factors identified within the NCEP ATP III guidelines, thereby 
indicating the need for cholesterol screening.
Methods of Data Collection
Prior to conducting the current research, approval was obtained from Mississippi 
University for Women’s Institutional Review Board (IRB) (see Appendix A). After 
approval from the IRB, each research team member contacted the manager/provider of 
each clinic where he/she wished to review charts in order to obtain written consent (see 
Appendix B) to review charts. The members o f the research group also met with each 
respective clinic manager to obtain permission to access electronic medical records 
and/or paper charts for the purpose of data collection. The office secretary or office-
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delegated staff member performed a search o f the respective clinic’s electronic patient 
databases using the criteria of 20 to 40 years old, male or female, and provided the 
researchers with a list of patients meeting the age and gender criteria for cholesterol 
screening. One hundred charts were randomly selected from this list by selecting every 
10*̂  medical record for review. All patients selected had been seen in the clinic within 
the last 5 years. One clinic included in the current research still utilized paper charts.
In this clinic, the office manager manually pulled any chart and set aside those charts 
belonging to a patient between 20 and 40 years of age. The manager did this until 100 
charts were pulled.
The medical records were reviewed in a secure area away from clinic traffic and 
patient care areas. Data were collected confidentially in the designated area approved 
by office management. Once data collection was completed, each researcher returned 
the charts to the medical records department or the pre-designated area for chart return. 
If electronic records were utilized, the research team member logged off the designated 
device and returned the device and/or user access code information to office 
management.
A data collection worksheet was utilized by each research team member to 
collect data (see Appendix C). The data collection worksheet did not contain any 
confidential, identifying information, such as the clinic name, patient name, medical 
record number, social security number, birthdate, or address. All data were entered into 
a word processing document and stored on a single-password-protected USB drive 
secured in a location accessible only to the researchers. Upon completion of the 
research, all media and paper data were appropriately destroyed.
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Protection of Subjects
Prior to data collection, written approval for the current research was obtained 
from Mississippi University for Women’s IRB. Data were collected by a retrospective 
chart review that did not involve any direct testing or human subjects. All charts 
remained in the medical clinic with patient confidentiality being maintained at all times 
in accordance with the Health Insurance Portability and Accountability Act (HIPAA). 
Access to patient information was limited to researchers during the review. The data 
collection worksheet did not contain any identifiable information pertaining to the 
clinics or patients. Information obtained from the data collection worksheet was saved 
on a secure universal serial bus (USB) flash drive.
Methods of Data Analysis
Data were collected on a researcher-designed worksheet and organized into a 
word processing document. Information captured on the data collection worksheet 
included age, gender, payer source, risk factors, type of healthcare provider, and 
whether or not a lipid panel was performed in the last 5 years. Data were then subjected 
to analysis using descriptive statistics including, but not limited to, frequency 
distributions and percentages. Data were analyzed for provider adherence to the NCEP 
ATP III guidelines and the incidence of a lipid profile being performed based on 
cardiovascular risk factors and demographic factors.
Summary
Research design, implementation, data collection, and data analysis were 
addressed in this chapter to determine if  providers are compliant with the NCEP ATP III 
guidelines. A quantitative, descriptive, retrospective review o f 500 charts was 
performed for the purposes o f the current research. Data were collected systematically
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and confidentially from a random convenience sample of medical records. Data 
analysis was performed to determine whether or not primary care providers in the 
southeastern United States were in compliance with the NCEP ATP III guidelines for 




The Centers for Disease Control and Prevention (2013) cites dyslipidemia as a 
lead risk factor in the development o f cardiovascular disease. Early identification of 
dyslipidemia by primary care providers allows for correction and management of 
cholesterol that may help prevent development of cardiovascular disease. Statistically, 
primary care providers are falling short in screening the general public for dyslipidemia. 
The purpose of the current research was to analyze the cholesterol screening practices 
o f primary care providers. The current research sought to determine if  patients between 
the ages of 20 and 40 years were being screened every 5 years with a fasting lipoprotein 
profile as recommended by the National Cholesterol Education Program guidelines 
(NCEP ATP III). This chapter describes the current research sample and answers the 
research questions by utilizing the current research. Statistical findings are also 
summarized in figures and tables.
Profile of Study Participants
Data for the current research were obtained by reviewing a convenience sample 
of 100 charts from 5 clinics in the southeastern United States. The sample included 
patients between the ages of 20 and 40 years. The selected charts represented patients 
that were treated in one o f the five respective clinics between 2011 and 2015, reflecting 
provider adherence to NCEP ATP III guidelines during those years. The data were 
manually extracted and recorded on a data collection worksheet. Specific demographic 
information abstracted from each chart included the patient’s age, gender, risk factors, 
provider type, and payer source. The researchers also recorded whether or not there 
was documentation of a fasting lipoprotein within the last 5 years.
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Age. The sample of charts reviewed consisted of 500 patients ranging in age 
from 20 to 40 years with 20.4% {n = 102) between 20 and 25 years of age, 21% (n = 
105) between 26 and 30 years of age, 30.2% (n= 151 between 31 and 35 years of age, 
and 28.4% (n = 142) between 36 and 40 years of age. The mean age was 31.35 years of 
age. Figure 1 illustrates the percentage of participants in each age group.
Percentage of Patients per Age Group
28.4%
20-25 Years of Age ■ 26-30 Years of Age ■ 31-35 Years of Age ■ 36-40 Years of Age
Figure 1. Percentage of participants in each age group.
Gender. The sample was comprised of more female than male participants.
The sample included 40% males {n = 199) and 60% females (n = 301). Figure 2 depicts 
the percentage of the gender distribution in the sample population.
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GENDER
I Male ■ F em ale
Figure 2. Percentage of gender distribution in the sample population.
Provider type. The researchers assessed which type of provider managed the 
participants’ care. O f the 500 participants, 65% (n = 327) were treated by a nurse 
practitioner and 34.6% (n = 173) were treated by a physician. Figure 3 presents the 
percentage of the sample treated by each type of provider.
Payer source. O f the 500 patients, the most common payer source was private 
insurance at 49.6% (n = 248), followed by self-pay at 37.2% (n = 186), and 13.2% {n = 
66) covered under a government program which includes the Medicare and Medicaid 






Physician ■  Nurse Practitioner







Private Insurance Self-Pay Governm ent Program
Figure 4. The payer source of the participants.
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Statistical Results
A total o f 500 charts were chosen at random to complete this retrospective chart 
review. The only requirement while randomly choosing charts was that the charts 
belonged to patients between the ages of 20 and 40 years. The current researchers 
collaborated with a professional statistician to organize the information from the data 
collection worksheets in a Microsoft Excel spreadsheet. Data were analyzed by the 
statistician using UMB SPSS statistical software, version 21. Analyses were performed 
to answer the three research questions presented in this study. Chi-square analyses were 
performed to determine if  demographics affected the cholesterol screening practices of 
primary care providers. The researchers investigated the following research questions:
1. Are primary care providers performing a fasting lipoprotein profile on 
patients between the ages o f 20 and 40 years once every 5 years?
2. Were risk factors present in the patients who had a fasting lipoprotein profile 
performed?
3. Were risk factors present in the patients who did not have a fasting 
lipoprotein profile performed?
Research question 1. Are primary care providers performing a fasting 
lipoprotein profile on patients between the ages of 20 and 40 years once every 5 years? 
O f the 500 charts reviewed, 211 patients (42.2%) had a fasting lipoprotein profile 
performed in the past 5 years. Providers failed to perform a fasting lipoprotein profile 
on 289 patients (57.8%). Figure 5 represents these findings.
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Provider Compliance to NCEP ATP III Guidelines
Compliant ■ Non-Compliant
Figure 5. Provider compliance to NCEP ATP III guidelines.
Research question 2. Were risk factors present in the patients who had a 
fasting lipoprotein profile performed? Of the 500 patient charts reviewed, 42.2% {n = 
211) of the participants had a fasting lipoprotein performed in the past 5 years.
Analyses were performed to determine if any cardiovascular risk factors were present. 
Table 1 summarizes the percentage of patients who had each risk factor. The current 
research found that 50.2% {n = 106) of screened patients had the diagnosis of 
hypertension, and 43.1% (n = 91) of screened patients were taking hypertensive 
medications. These were the most common risk factors present in the patients that were 
screened by the primary care provider. Furthermore, 28.9% (/2 = 61) of the patients that 
were screened exhibited at least two of the risk factors on the data collection worksheet.
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Figure 6 presents the number of risk factors present in the 211 patients in which a 
lipoprotein profile was performed.
Table 1
Presence o f  Risk Factors fo r  Patients with Fasting Lipoprotein Profile Performed
Present
Risk Factor n %
Absent
%
Family history of cardiovascular disease 46 21.8 165 78.2
Tobacco use 39 18.5 172 81.5
Hypertension 106 50.2 105 49.8
Prescribed hypertension medication 91 43.1 120 56.9
Obesity 67 31.8 144 68.2













N u m b er o f  Risk F actors
Figure 6. Frequency of risk factors in patients who were screened with a lipoprotein 
profile.
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Research question 3. Were risk factors present in the patients who did not have 
a fasting lipoprotein profile performed? Of those patients who were not screened, 43.9% 
(n = 127) had zero risk factors present. O f the remaining 169 patients, obesity and 
tobacco use were the most common risk factors present. Table 2 presents the 
percentage of unscreened patients who had each or did not have a specific risk factor.
Table 2
Presence o f  Risk Factors fo r  Patients Without Fasting Lipoprotein Profile Performed
Present Absent
Risk Factor n % n Vo
Family history o f cardiovascular disease 33 11.4 256 88.6
Tobacco use 59 20.4 230 79.6
Hypertension 47 16.3 242 83.7
Prescribed hypertension medication 43 14.9 246 85.1
Obesity 71 24.6 218 75.4
Note, n = 289.
The patients (n = 289) who were not screened were evaluated for the presence of 
cardiovascular risk factors. Figure 7 presents the number o f risk factors present in the 















N u m b er o f  Risk F actors
Figure 7. Frequency o f risk factors in patients who were not screened with a 
lipoprotein profile.
Other results. In addition to answering the stated research questions, chi-square 
analyses were performed to determine if individual demographic factors influenced 
cholesterol screening practices of primary care providers. In relation to payer source, 
chi-square analyses revealed that 43.3% {n = 248) of insured patients, 38.2% {n = 186) 
of self-pay patients, and 53% (« = 66) of government assistance patients were screened. 
Therefore, the chi-square proved that there is no statistically significant effect on payer 




Chi-square Analysis Performed on Payer Source
Payer source n % patients screened
Insurance 248 42.3
Self-pay 186 38.2
Government program 66 53.0
Chi-square analysis - i i l ,  N =  500) = 4 A \ 3 , p =  .110
Additionally, 43.2% of male patients and 41.5% o f female patients were 
screened with a lipoprotein profile. This finding revealed that there is no statistical 
significance between gender and cholesterol screening practices. Table 4 shows the 
chi-square analysis performed on gender type.
Table 4
Chi-square Analysis Performed According to Gender








3Ĉ (2, iV= 500) = ,140,/7 = .708
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Chi-square analysis revealed there was a statistically significant difference in 
provider type and clinic location. Physicians were significantly more likely to perform 
a cholesterol screening when compared to their nurse practitioner counterparts. These 
results are represented in Table 5.
Table 5
Chi-square Analysis o f  Provider Type
Provider type n % patients screened
MD 327 55.0
NP 173 17.9
Chi-square analysis %^(l, N =  500) = 63.938,/) = < .001
Additionally, Clinics Two, Three, and Four were more likely to perform a 
lipoprotein profile than Clinics One and Five. Another important factor is that 
physicians were the providers who signed for the majority o f the charts in Clinics Two, 
Three, and Four. Therefore, the clinic result is considered identical to the 
physician/nurse practitioner result. The results are displayed in Table 6.
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Table 6
Chi-square Analysis o f  Clinic Sites






Chi-square analysis 5Ĉ (4, N =  500) = 90.638,/) = < .001
Data Analyses
Data were collected from patient charts at 5 respective clinics located in the 
southeastern United States and entered on a researcher-developed data collection 
worksheet. Data were then entered into Microsoft Excel and sent to a professional 
statistician for analyses in an effort to accurately answer the three research questions.
Data analyses revealed primary care providers were compliant with only 42.2% 
of patients when performing cholesterol screenings. Data also revealed that physicians 
were more likely to perform a lipoprotein profile than nurse practitioners. No 
significance was noted in regard to payer source or gender. Hypertension and 
hypertensive medications were the diagnoses most likely to be seen in patients who 
were screened with a lipoprotein profile.
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Summary of Findings
Chapter IV presented the researchers’ findings fi*om the current retrospective 
chart review of 500 patients fi*om five clinics in the southeastern United States. 
Findings from the demographics and research questions were presented in figures and 
tables for comparison. The results of this analysis revealed overall noncompliance 
among primary care providers in regard to following the NCEP ATP III guidelines. 
These conclusions highlight the opportunity for improvement among primary care 




According to the Centers for Disease Control and Prevention (2014b), 
cardiovascular disease affects over 82 million American adults and is currently the 
leading cause of death in the United States. High cholesterol is one of the main risk 
factors in the development o f this disease process (CDC, 2014a). Hypercholesterolemia 
can result in the vascular system becoming unable to dilate, thus resulting in hardening 
of the arterial walls which is known as atherosclerosis. Atherosclerosis can lead to a 
compromised vasculature system. Cholesterol plaque buildup can dislodge from the 
vessels resulting in myocardial infarction or cerebrovascular accident (National Health, 
Lung, and Blood Institute [NHLBI], 2012). The purpose of the current research was to 
determine if  primary care providers are screening adults between the ages o f 20 and 40 
years for high-blood cholesterol levels. The researchers used recommendations stated 
in the National Cholesterol Education Program, Adult Treatment Panel III guidelines 
(NCEP ATP III) (James & Cleeman, 2001).
Compliance was evaluated by three research questions:
1. Are primary care providers performing a fasting lipoprotein profile on 
patients between the ages of 20 and 40 years once every 5 years?
2. Were risk factors present in the patients who had a fasting lipoprotein profile 
performed?
3. Were risk factors present in the patients who did not have a fasting 
lipoprotein profile performed?
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Nola J. Pender’s Health Promotion Model was used as the theoretical framework 
to guide the current research. A summary of the findings, implications of the results, 
and recommendations for further research are presented in this chapter.
Summary of the Findings
The sample consisted of 500 participants. The participants received care at one 
of the five primary care clinics in the southeastern United States between 2011 and 
2015. The sample consisted o f 199 males and 301 females. The average age was SD = 
31.35 years. The primary payer source was private insurance at 49.6% (n = 248), 
followed by self-pay at 37.2% (n = 186); and 13.2% {n = 66) were covered under a 
government program which includes the Medicare and Medicaid programs. Physicians 
were the primary care provider for 85.3% of the sample with nurse practitioners 
managing the care of 14.7% of the participants.
Discussion of the Findings
The researchers found that 289 patients or 57.8% did not have a fasting 
lipoprotein level checked every 5 years by a primary care provider. This equates to a 
compliance rate o f only 42.2% by primary care providers. Hypertension was the most 
prevalent risk factor among those who were screened, followed by those on prescription 
hypertension medication and obesity. Of the patients who did not receive a fasting 
lipoprotein profile screening, obesity and tobacco use were the most common risk 
factors present, followed by hypertension and prescribed hypertension medication.
Chi-square analyses were performed to determine if  individual demographic 
factors influenced cholesterol-screening practices. There was no statistical significance 
effect on payer type and screening practices. There was also no statistical significance 
between gender and cholesterol screening practices. There was, however, a statistical
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difference in provider type and screening practices. Physicians were significantly more 
likely to perform a cholesterol screening when compared to nurse practitioners. Clinics 
Two, Three, and Four were more likely to perform lipoprotein profiles than Clinics One 
and Five. It is important to note that in Clinics Two, Three, and Four the charts were 
completed by physicians, and in Clinics One and Five the charts were completed by 
nurse practitioners.
The current researchers found that 289 patients or 57.8% did not have a fasting 
lipoprotein level checked every 5 years by a primary care provider. This leaves a 
compliance rate of only 42.2% by primary care providers. The reason for the 
noncompliance is unknown, as it was not documented in any medical records. 
Noncompliance could be attributed to lack of education on the part of the provider or 
lack of education on the part o f the patient. It could also be associated with the patient 
seeing another provider for his or her wellness visits. Financial burdens could also be a 
factor; yet, there were no significant statistical differences in payer source.
In the study by Barham et al. (2009), a total of 5,031 patients between the ages 
of 20 and 84 years were examined from 61 community practices. The total screening 
rate was 34.5%, which is near the NCEP ATP III goal of 40% (Barham et al., 2009). 
This is in contrast to the current research, which yielded a total screening rate of 42.2%, 
which is above the NCEP ATP III goal. Barham et al. (2009) also found that older 
patients were more likely to be screened but less likely to be appropriately treated. The 
current research did not include such a broad age variation; therefore, it was unable to 
analyze the significance o f age and screening practices.
Kuklina et al. (2010) conducted a study o f cholesterol screening practices using 
the National Health and Nutrition Examination Survey (NHANES), a multistage
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probability design to select participants to survey the nutritional status of the United 
States. Kuklina et al. analyzed a sample size of 2,587 patients. O f the 2,587, 50% of 
women between the ages of 20 and 45 years and 40% of men between the ages o f 20 
and 40 years were screened for high cholesterol (Kuklina et al., 2010). Even though 
these findings met the NCBP ATP III goals, Kuklina et al. (2010) still argued that 
young adults are not being screened as frequently as they should. Kuklina et al. (2010) 
used a sample size 5 times larger than the student research and were still able to receive 
a better screening outcome than the current research. Kuklina et al. (2010) offered no 
reasoning as to why the screening rates were low to average. Kuklina et al. suggested 
that future studies be conducted to improve cholesterol screenings in younger adults.
The current research coincides with Kuklina et al.’s (2010) findings and also supports 
the fact that screening practices need improvement.
Research performed by Johansen et al. (2014) helped develop the current study’s 
data collection form by emphasizing the importance of risk factors in preventing 
cardiovascular disease. Johansen et al. included individuals between the ages o f 30 and 
79 years. This resulted in the analysis o f 16,712 individuals (Johansen et al., 2014). 
Johansen et al. (2014) found that many patients who were not diagnosed with 
hyperlipidemia were undermanaged. Undermanagement of this significant risk factor 
put them at an unnecessary risk for developing cardiovascular disease (Johansen et al., 
2014). These findings support the current research by emphasizing the importance of 
screening all patients for risk factors.
Pletcher et al. (2010) studied 5,115 men and women in an attempt to determine 
if  hyperlipidemia present in 18- to 30-year-olds was positively associated with the 
development of coronary heart disease 15 to 20 years later. The participants were
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evaluated periodically through scheduled lipoprotein levels. Pletcher et al. (2010) 
found a positive correlation with increased lipid levels in young adulthood and the 
presence of hyperlipidemia and coronary calcium scores 15 to 20 years later. The 
presence of abnormal lipids was most commonly associated with white males, a 
premature coronary heart disease risk, increased BMl and waist circumference 
measurements, diabetes, a sedentary lifestyle, and consumption of alcohol (Pletcher et 
al., 2010). The risk factors for obesity and a premature heart disease risk coincided with 
the risk factors used in the student research. Pletcher et al. (2010) stated that young 
adults with even a slight increase in LDL were at a higher risk of developing 
cardiovascular disease later in life. This supports and emphasizes the importance o f the 
current research and the need for proper cholesterol screening.
Parker et al. (2008) performed a study to identify barriers that primary care 
providers felt existed when implementing the NCEP ATP 111 guidelines. Nine separate 
focus groups were organized with a total o f 300 primary care providers. Parker et al. 
concluded that the barriers physicians identified included the following: (a) physician 
perceived guideline complexity, (b) lack of accessibility and guidance in guideline 
interpretation in rural practices, (c) patient noncompliance with provider 
recommendations, (d) patients’ inability to afford guideline-related test or drugs, and (e) 
time constraints during patient encounters. The study performed by Parker et al. (2008) 
related to the current research by providing insight as to why only 42.2% of the patients 
were screened for cholesterol.
Studies conducted by Barham et al. (2009), Johansen et al. (2014), Kuklina et al. 
(2010), Parker et al. (2008), and Pletcher et al. (2010 support the current research and 
emphasize the importance of cholesterol screenings. It is evident that there is a need to
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abide by the NCEP ATP III guidelines for proper lipoprotein screenings. Emphasis 
should be placed on the importance of cholesterol screenings, and education should be 
provided to promote safer practices in primary care.
Limitations of the Research
Limitations were identified in the current research. Limitations included small 
sample size, limited data collection, and the use of convenience sampling. These 
limitations decreased the reliability of the findings, limited the representation of the 
sample studied, and misrepresented practice in other parts o f the country.
The small sample size of only 500 charts decreased the reliability of screening 
practices by primary care providers. The small sample would likely not be of sufficient 
size to make any accurate assumptions of the screening practices o f these clinics, other 
clinics in the area, or clinics in the remainder o f the state. Using clinics in more areas of 
the state, as well as using clinics in various other states, would have increased the 
reliability o f provider screening practices.
Data collection was limited to clinics located in one state located in the 
southeastern United States. Limitation to this geographic location may not be 
applicable to other geographic areas of the country. Therefore, the results may not 
appropriately represent the practices of other clinics across the United States. Again, 
expanding future research to other areas of the United States would give a better overall 
view of how primary care providers are screening patients for cholesterol levels.
The use of random, convenience sampling reduced the reliability of the current 
research. Convenience sampling represented the results o f only the charts reviewed 
rather than the entire client population of each clinic, this may have caused the results to 
be limited and atypical o f the population in the region being studied. This limitation
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could be corrected by selecting subjects that were representative of the population as a 
whole.
Implications
Major implications can be made from the results o f the current research. In the 
southeastern United States, the increased prevalence of cardiovascular disease remains 
high. Furthermore, high-blood cholesterol is a contributing factor. Approximately half 
o f the primary care providers in the current research were not compliant with NCEP 
ATP III guidelines. The current research provided areas o f focus for performance 
improvement in primary care clinics and increased positive outcomes among patients 
meeting criteria for cholesterol screening. An educational opportunity is identified for 
nursing schools, medical schools, and physician assistant programs potentially 
increasing compliance with guidelines by providing educational information while 
training new primary care providers. Additionally, future research and nursing theory 
may benefit from the implications drawn from the current research.
Clinical practice. Hyperlipidemia increases the risk o f developing 
cardiovascular disease. The results of the current research indicated that primary care 
providers in the southeastern United States are noncompliant with the NCEP ATP III 
guidelines for routine cholesterol screening, thus increasing the risks of adverse 
outcomes related to elevated cholesterol. With poor compliance identified, primary 
care providers should increase efforts to maintain or obtain continuing education in 
regard to the evidence-based practice of cholesterol screening. Additionally, primary 
care providers must provide teaching to patients in regard to maintaining healthy 
cholesterol levels. By improving clinical practice standards, nurse practitioners and 
physicians can delay or prevent the onset o f cardiovascular disease in adults between
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the ages o f 20 and 40 years. By increasing awareness of current cholesterol screening 
guidelines, the primary care provider will be in a position to promote healthy behaviors, 
properly screen patients for elevated cholesterol, and prevent or manage related diseases 
accordingly.
Education. The current research concludes that there is a need for further 
education of primary care providers, healthcare professionals, and the general public on 
the significance of cholesterol’s effects on the development of cardiovascular disease 
and the importance o f cholesterol screenings to detect and treat high-cholesterol levels. 
The current research may educate primary care providers on the disparities of 
cholesterol screenings in young adults and raise awareness o f populations at risk of 
developing cardiovascular disease. The challenges o f staying educated on current 
guidelines and standards of practice have been identified fi*om the results of the current 
research. Primary care providers must realize the importance of continuing education 
and providing educational information to patients as a means of decreasing adverse 
outcomes in healthcare and increasing the quality of life for patients.
The clinics that participated in the current research will be provided a copy of 
the research findings. By utilizing the results of the current research, each individual 
clinic can develop a plan of action to increase compliance with the NCEP ATP III 
guidelines. Increasing the public’s awareness of the importance of cholesterol 
screening through patient education can and will empower patients to take an active role 
in their healthcare, thereby resulting in the prevention of future complications fi'om 
heart disease.
Research. Evidence-based practices originate with well-planned, designed, and 
orchestrated research. Implications for future research can be identified within the
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conclusions of the current research. The first implication is that additional research 
should be performed investigating the low compliance rate to the current cholesterol 
guidelines, whether the reason is a lack of knowledge of the current guidelines or 
simply healthcare provider oversight when ordering tests. Future research is also 
needed to investigate compliance rates on a larger scale within the designated area to 
determine if  the low compliance rate was only within the current resarch sample or if 
the problem of compliance is more widespread. Replication of the current research on a 
larger scale with a larger population and geographical area will determine if  guideline 
compliance rates are similar across the country or a problem in an isolated geographical 
region.
As the use of electronic medical records increases, future research is needed to 
investigate different systems. Future research should evaluate if  a system’s built-in 
reminders for required labs, in particular diagnoses or age groups, increases compliance. 
Researching for increased compliance rates in systems containing alerts versus systems 
that do not have built-in reminders may indicate the need for improved electronic 
medical records.
Nursing theory. Nola Pender’s Health Promotion Model (HPM) was selected 
by the researchers as the theoretical foundation for the current research. The HPM is a 
nursing theory developed to understand and predict what factors, including biological, 
psychological and environmental, determine a person’s health behaviors. This theory 
emphasizes health promotion and disease prevention using positive motivation, and the 
desired outcome is a health-promoting behavior. In the current research, the HPM was 
used as a guide to determine how effectively healthcare providers emphasized the 
importance of cholesterol screening. Utilizing the concepts and assumptions identified
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within the HPM, the primary care provider can impact the patient by educating patients 
on the risk factors that may increase their cholesterol and introduce interventions to 
improve the cardiovascular health of individuals. Additionally, compliance 
improvement could be accomplished through the education of primary care providers 
and the identification of potential obstacles in following NCEP ATP III guidelines. By 
utilizing the HPM, the development of strategies to overcome any apparent obstacles 
could improve compliance with NCEP ATP III guidelines for healthcare providers and 
patients.
Conclusions
The purpose o f the current research was to determine whether or not primary 
care providers were screening adults between the ages of 20 and 40 years for high-blood 
cholesterol levels. The current research evaluated the cholesterol screening practices of 
primary care providers according to recommendations stated in the NCEP ATP III 
guidelines. The current research also identified the presence of cardiovascular disease 
risk factors in patients who were screened and who were not screened. Overall, 42.2% 
of the patients studied had a fasting lipid profile performed versus 57.8% o f the patients 
studied who did not have a fasting lipid profile performed within the last 5 years. The 
current research concluded that physician providers were significantly more likely to 
perform fasting lipid screen than nurse practitioner providers. Physicians appropriately 
screened 55% of the 327 patients they treated. Nurse practitioners only screened 17.9% 
of the 173 patients they treated.
The 211 patients who received screening were further evaluated to determine the 
presence of risk factors. The most prevalent risk factor was hypertension in 50.2% of 
the screened patients, followed by patients receiving a prescription for hypertensive
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medication at 43.1%. The family history of cardiovascular disease, tobacco use, and 
obesity were also included as risk factors. O f the patients who were screened with a 
fasting lipoprotein, 21.8% had a family history o f cardiovascular disease, 39% had a 
history of tobacco use, and 31.8% had a history of obesity.
Conversely, the 289 patients who were not screened with a fasting lipoprotein 
were also evaluated to determine the presence o f risk factors. The most prevalent risk 
factor in those who did not receive screening was obesity at 24.6%, followed by a 
history o f tobacco use at 20.4%. Other risk factors included a history o f hypertension at 
16.3%, history of prescribed hypertensive medications at 14.9%, and family history of 
cardiovascular disease at 11.4%.
The current research concluded there were statistically significant differences in 
cholesterol screening based on a clinic. Clinics Two, Three, and Four were 
significantly more likely to perform cholesterol screening than Clinics One and Five. It 
is important to note that Clinics Two, Three, and Four were composed primarily of 
physician providers.
Additionally, the current research evaluated whether payer source affected 
cholesterol screening practices. The current research found that 53% of the 66 patients 
that were a government insurance program were screened, 42.3% of 248 privately 
insured patients were screened, and 38.2% of the 66 self-pay patients were screened. 
Therefore, payer source did not significantly affect cholesterol screening.
Based on the current research, primary care providers are not consistently 
following the NCEP ATP III guidelines when routinely performing cholesterol 
screening in adults between the ages of 20 and 40 years. The current research
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concluded that primary care providers need additional education regarding the NCEP 
ATP III guidelines for cholesterol screening.
Recommendations
Based on the results o f the current research, the following recommendations are 
made for primary care providers:
• Obtain and maintain continuing education in regard to the evidence-based 
practice of cholesterol screening.
• Increase the public’s awareness of the importance o f cholesterol screening at 
any age through patient education.
• Replicate the current research on a larger scale with a larger population and 
geographical area to determine if  guideline compliance rates are similar 
across the country or a problem in an isolated geographical region.
• Include the subject’s race within the demographics to identify any disparities 
involving cholesterol screening practices and ethnicity.
• Investigate the compliance rate among a variety o f primary health providers, 
including physician’s assistants and doctors of osteopathy.
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conducting a retrospective chart review to assess provider compliance to the National 
Cholesterol Education Program’s cholesterol screening protocol. We will be looking 
specifically for adherence to the national guidelines for cholesterol screening. The 
students that are participating in the current research are Constance Harthcock,
Christina Jordan, Jane Mattina, Kristen McPherson, and Bradley Myers.
We are requesting your permission to utilize your clinic as one of the settings for our 
study. By providing us with permission, we will have access to your patients’ medical 
records for a retrospective chart review. We recognize the essential need for 
confidentiality in regard to patient health information. Each student has completed a 
HIPAA training workshop through Mississippi University for Women. The students 
further agree to protect all information obtained, and no identifying information will be 
recorded. We will be utilizing a student-designed data collection worksheet to collect 
the required information. A copy of this tool is included with this letter. We will load 
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